CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-23 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Units | −7,012 | 21,033 | ||
| 2025-02-23 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise | +6,688 | 35,501 | ||
| 2025-02-23 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −3,601 | $57.75 | $208K | 31,900 |
| 2025-02-23 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −6,688 | 20,063 | ||
| 2025-02-23 | Torley Helen PRESIDENT AND CEO | Option exercise | +22,436 | 745,800 | ||
| 2025-02-23 | Torley Helen PRESIDENT AND CEO | Shares withheld for taxes | −12,081 | $57.75 | $698K | 733,719 |
| 2025-02-23 | Torley Helen PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −22,436 | 67,308 | ||
| 2025-02-20 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Option to Purchase Common Stock | +11,902 | 11,902 | ||
| 2025-02-20 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Grant or award · Restricted Stock Units | +11,230 | 11,230 | ||
| 2025-02-20 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Grant or award · Option to Purchase Common Stock | +22,603 | 22,603 | ||
| 2025-02-20 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Grant or award · Restricted Stock Units | +21,327 | 21,327 | ||
| 2025-02-20 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Option to Purchase Common Stock | +22,603 | 22,603 | ||
| 2025-02-20 | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +21,327 | 21,327 | ||
| 2025-02-20 | Torley Helen PRESIDENT AND CEO | Grant or award · Option to Purchase Common Stock | +71,038 | 71,038 | ||
| 2025-02-20 | Torley Helen PRESIDENT AND CEO | Grant or award · Restricted Stock Units | +67,027 | 67,027 | ||
| 2025-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise | +20,891 | 196,729 | ||
| 2025-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −8,721 | $58.29 | $508K | 188,008 |
| 2025-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise | +6,112 | 194,120 | ||
| 2025-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Shares withheld for taxes | −3,103 | $58.29 | $181K | 191,017 |
| 2025-02-16 | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | Option exercise | +4,263 | 195,280 |
Page 20 of 26 · 513 trades